CNPAX
Price
$70.41
Change
-$2.56 (-3.51%)
Updated
Feb 3 closing price
Net Assets
162.72B
LSCGX
Price
$21.33
Change
-$2.19 (-9.31%)
Updated
Feb 3 closing price
Net Assets
131.4M
Interact to see
Advertisement

CNPAX vs LSCGX

Header iconCNPAX vs LSCGX Comparison
Open Charts CNPAX vs LSCGXBanner chart's image
American Funds New Perspective 529A
Price$70.41
Change-$2.56 (-3.51%)
VolumeN/A
Net Assets162.72B
Loomis Sayles Global Growth C
Price$21.33
Change-$2.19 (-9.31%)
VolumeN/A
Net Assets131.4M
CNPAX vs LSCGX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. LSCGX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and LSCGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. LSCGX (131M). CNPAX pays higher dividends than LSCGX: CNPAX (0.99) vs LSCGX (0.00). CNPAX was incepted earlier than LSCGX: CNPAX (24 years) vs LSCGX (10 years). LSCGX (2.13) is less costly to investors than CNPAX (0.74). CNPAX is a more actively managed with annual turnover of: 23.00 vs. LSCGX (6.00). CNPAX has a lower initial minimum investment than LSCGX: CNPAX (250) vs LSCGX (2500). CNPAX annual gain was more profitable for investors over the last year : 12.85 vs. LSCGX (4.46). CNPAX return over 5 years is better than : 17.17 vs. LSCGX (14.55).
CNPAXLSCGXCNPAX / LSCGX
Total Expense Ratio0.741.9538%
Annual Report Gross Expense Ratio0.742.1335%
Fund Existence24 years10 years-
Gain YTD1.602-4.221-38%
Front Load4%N/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets163B131M124,427%
Annual Yield % from dividends0.990.00-
Returns for 1 year12.854.46288%
Returns for 3 years41.1256.6173%
Returns for 5 years17.1714.55118%
Returns for 10 years136.09N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYTLF0.020.01
+40.63%
HYTERRA LTD.
LNWO121.814.66
+3.98%
Light & Wonder, Inc.
SJMHF0.30N/A
N/A
SJM Holdings Ltd.
VSBC1.00N/A
N/A
VitaSpring Biomedical Co. Ltd.
RHHVF452.20-2.42
-0.53%
Roche Holding Ltd